Inosine Stimulates Chemotaxis, Ca2+-Transients and Actin Polymerization in Immature Human Dendritic Cells via a Pertussis Toxin-Sensitive Mechanism Independent of Adenosine Receptors

Journal of Cellular Physiology

Volumn 199, Issue 1, 2004, Pages 149-156

  Idzko, Marco ^a   Panther, Elisabeth ^a   Bremer, Hinrich C ^a   Windisch, Wolfram ^a   Sorichter, Stephan ^a   Herouy, Yared ^a   Elsner, Peter ^b   Mockenhaupt, Maja ^a   Girolomoni, Giampiero ^c   Norgauer, Johannes ^b,d  

^a UNIVERSITY OF FREIBURG   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^d Department of Dermatology ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; B7 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; HLA DR ANTIGEN; INOSINE; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PERTUSSIS TOXIN; TUMOR NECROSIS FACTOR ALPHA;

ACTIN POLYMERIZATION; ANTIGEN PRESENTING CELL; ARTICLE; BLOOD; CELL MEMBRANE; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; LYMPHOID ORGAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACTINS; ANTIGENS, CD; CAFFEINE; CALCIUM; CELL DIFFERENTIATION; CHEMOTAXIS; CYTOKINES; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INOSINE; PERTUSSIS TOXIN; QUINAZOLINES; RECEPTORS, PURINERGIC P1; TRIAZOLES; XANTHINES;

EID: 10744219511     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10431     Document Type: Article

References (43)

1. Banchereau J, Steinman RM. 1998. Dendritic cells and the control of immunity. Nature 392:245-252.
2. Bell MJ, Kochanek PM, Carcillo JA, Mi Z, Schiding JK, Wisniewski SR, Clark RSB, Dixon CE, Marion DW, Jackson E. 1998. Interstitial adenosine, inosine, and hypoxanthine are increased after experimental traumatic brain injury in the rat. J Neurotrauma 15:163-170.
3. Bonifaz L, Bonnyay D, Mahnke K, Rivera M, Nussenzweig MC, Steinman RM. 2002. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J Exp Med 196:1627-1638.
4. Born GVR, Kratyer MAA. 1984. Source and concentration of extracellular adenosine triphosphate during haemostasis in rats, rabbits, and man. J Physiol 354:419-426.
5. Caux C, Vanbervliet B, Massacrier C, Ait-Yahia S, Vaure C, Chemin K, Dieu-Nosjean MC, Vicari A. 2002. Regulation of dendritic cell recruitment by chemokines. Transplantation 73:S7-S11.
6. Crane JK, Olson RA, Jones HM, Duffey ME. 2002. Release of ATP during host cell killing by enterpathogenic E. coli and its role of secretory mediator. Am J Physiol Gastrointest Liver Physiol 283:G74-G86.
7. Dale N, Pearson T, Frenguelli BG. 2001. Direct measurements of adenosine release during hypoxia in the CA1 region of the rat hippocampal slice. J Physiol 526:143-155.
8. Dichmann S, Rheinen H, Panther E, Herouy Y, Czech W, Termeer C, Simon JC, Gebicke-Haerter P, Norgauer J. 2000. Downregulation of platelet activating factor responsiveness during maturation of human dendritic cells. J Cell Physiol 185:394-400.
9. Dunwiddie TV, Diao L, Proctor WR. 1997. Adenine nucleotides undergo a rapid quantitative conversion to adenosine in the extracellular space in rat hippocampus. J Neurosci 17:7673-7682.
10. Ehlers FJ. 1992. Allosterism and drug action. Proc West Pharmacol Soc 35:215-222.
11. Fosetta J, Jackson J, Gregory D, Xuedong F, Du X, Bober L, Soude-Bermejo A, de Bouteiller O, Caux C, Lunn C, Lundell D, Palmer RK. 2002. Pharmacological analysis of calcium responses mediated by the A3 adenosine receptor in monocyte-derived dendritic cells and recombinant cells. Mol Pharmacol 63:342-350.
12. Gallucci S, Matzinger P. 2001. Danger signals: SOS to the immune system. Curr Opin Immunol 13:114-119.
13. Gao Z, Li BS, Day YJ, Linden J. 2000. A3 adenosine receptor activation triggers phosphorylation of protein kinase B and protects rat basophilic leukemia 2H3 mast cells from apoptosis. Mol Pharmacol 59:76-82.
14. Geissmann F, Dieu-Nosejan MC, Dezutter C, Valladeau J, Kayal S, Leborgne M, Brousse N, Saeland S, Davoust J. 2002. Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J Exp Med 196:417-430.
15. Hasko G. 2001. Receptor-mediated interaction between the sympathetic nervous system and immune system in inflammation. Neurochem Res 26:1039-1044.
16. Hasko G, Kuhel DG, Nemeth YH, Mabley JG, Stachlewitz RF, Virag L, Lohinai Y, Southan GJ, Salyman AL, Szabo C. 2000. Inosine inhibits inflammatory cytokine production by a posttrancriptional mechanism and protects against endotoxin-induced shock. J Immunol 164:1013-1019.
17. Hasko G, Deitch EA, Szabo C, Nemeth ZH, Vizi ES. 2002. Adenosine: A potential mediator of immunosuppression in multiple organ failure. Curr Opin Pharmacol 2:440-444.
18. Idzko M, Dichmann S, Ferrari D, Di Virgilio F, la Sala A, Girolomoni G, Panther E, Norgauer J. 2002a. Nucleotides induce chemotaxis and actin polymerization in immature but not mature human dendritic cells via activation of pertussis toxin-sensitive P2Y receptors. Blood 100:925-932.
19. Idzko M, Panther E, Corinti S, Morelli A, Ferrari D, Herouy Y, Dichmann S, Mockenhaupt M, Gebicke-Haerter P, Di Virgilio F, Girolomoni G, Norgauer J. 2002b. Sphingosine 1-phosphate induces chemotaxis of immature and modulates cytokine-release in mature dendritic cells for emergence of Th2 immune responses. FASEB J 16:625-627.
20. Jabs CM, Neglen P, Eklof B. 1995. Breakdown of adenine nucleotides, formation of oxygen free radicals, and early markers of cellular injury in endotoxic shock. Eur J Surg 161:147-155.
21. Jin X, Shepherd RK, Duling BR, Linden J. 1997. Inosine binds to the A3 adenosine receptors and stimulates mast cell degranulation. J Clin Invest 100:2849-2857.
22. Jones CE, Thomas JX, Devous MD, Norris CP, Smith EE. 1997. Positive inotropic response to inosine in the in situ canine heart. Am J Physiol 233:H438-H441.
23. Juhasz-Nagy A, Aviado DM. 1977. Inosine as acardiotonic agent that reverses adrenergic β blockade. J Pharmacol Exp Ther 202:683-695.
24. Kalchar HM, Lowrz OH. 1947. The relationship between traumatic shock and the release of adenosine compounds. Am J Physiol 149:240-245.
25. Kuzmin AI, Lakomkin AL, Kapelko VI, Vassort G. 1998. Interstitial ATP level and degradation in control and postmyocardial infarcted rats. Am J Physiol 275:C766-C771.
26. la Sala A, Ferrari D, Corinti S, Cavani A, di Virgilio F, Girolomoni G. 2001. Extracellular ATP induces a distorted maturation of dendritic cells and inhibits their capacity to initiate Th1 responses. J Immunol 166:1611-1617.
27. Lennon PE, Taylor CT, Stahl GL, Colgan SP. 1998. Neutrophil-derived 5′-adenosine monophosphate promotes endothelial barrier function via CD73-mediated conversion to adenosine and endothelial A2b receptor activation. J Exp Med 188:1433-1443.
28. Liaudet L, Mabley JG, Parcher P, Virag L, Soriano FG, Marton A, Hasko G, Deitch EA, Szabo C. 2002. Inosine exerts a broad range of antiinflammatory effects in a murine model of acute lung injury. Ann Surg 235:568-573.
29. Lipscomb MF, Masten BJ. 2002. Dendritic cells: Immune regulators in health and disease. Physiol Rev 82:97-130.
30. Mabley JG, Pacher P, Liaudet L, Soriano FG, Hasko G, Marton A, Szabo C, Salzmann AL. 2003. Inosine reduces inflammation and improves survival in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol 284:G138-G144.
31. Merad M, Manz MG, Karsunky H, Wagers A, Peters W, Charo I, Weismann IL, Cyster JG, Engleman EG. 2002. Langerhans cells renew in the skin throughout life under staedy-state conditions. Nat Immunol 3:1135-1141.
32. Ninomiya H, Otani H, Lu K, Uchiyama T, Kido M, Imamura H. 2002. Complementary role of extracellular ATP and adenosine in ischemic preconditioning in rat heart. Am J Physiol Heart Circ Physiol 282: H1810-H1820.
33. Obata T, Yamanaka Y. 1998. Adenosine deaminidase activity in rat intestine: Assay with a microdialysis technique. Comp Biochem Physiol A Mol Integr Physiol 119:309-313.
34. Ohta A, Sitkokovsky M. 2001. Role of G-protein adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414:916-920.
35. Panther E, Idzko M, Herouy Y, Rheinen H, Gebicke-Haerter P, Mrowietz U, Dichmann S, Norgauer J. 2001. Expression and function of adenosine receptors in human dendritic cells. FASEB J 15:1963-1970.
36. Panther E, Corinti S, Idzko M, Herouy Y, Napp M, la Sala A, Girolomoni G, Norgauer J. 2003. Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T cell stimulatory capacity of human dendritic cells. Blood 101:3890-3895.
37. Rego AC, Santos MS, Oliveira CR. 1997. Adenosine triphosphate degradation products after oxidative stress and metabolic dysfunction in cultured retinal cells. J Neurochem 69:1228-1235.
38. Ryan JW, Smith U. 1971. Metabolism of adenonosine 5′ monophosphate during circulation through the lung. Trans Assoc Am Physicans 84:297-306.
39. Schmidt H, Siems WG, Grune T, Grauel EL. 1995. Concentration of purine compounds in the cerebrospinal fluid of infants suffering sepsis, convulsions, and hydrocephalus. J Perinat Med 23:167-174.
40. Sklar LA, Hyslop PA, Oades ZG, Omann GM, Jesaitis AJ, Painter RG, Cochrane CG. 1985. Signal transduction and ligand receptor dynamics in the human neutrophil. J Biol Chem 260:11461-11467.
41. Sozzani S, Allavena P, Vecchi A, Mantovani A. 2000. Chemokines and dendritic cell traffic. J Clin Immunol 20:151-160.
42. Steinman RM, Nussenzweig MC. 2002. Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci USA 99:351-358.
43. Wang T, Sodhi J, Mentzler RM, van Wylen DG. 1994. Changes in interstitial adenosine during hypoxia: Relationship to oxygen supply, demand imbalance, and effects on adenosine deaminidase. Cardiovasc Res 28:1320-1325.